31
Participants
Start Date
February 23, 2021
Primary Completion Date
June 18, 2022
Study Completion Date
December 1, 2025
Durvalumab
"IV infusions through induction phase.~IV infusions through maintenance phase until PD or other discontinuation criteria."
AZD2811
IV infusions through maintenance phase until PD or other discontinuation criteria.
Carboplatin
IV infusions through induction phase if chosen by Investigator.
Cisplatin
IV infusions through induction phase if chosen by Investigator.
Etoposide
IV infusions through induction phase.
Research Site, Cheongju-si
Research Site, Seville
Research Site, Valencia
Research Site, Grand Rapids
Research Site, Jinju
Research Site, Bydgoszcz
Research Site, Olsztyn
Research Site, Poznan
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Lead Sponsor
AstraZeneca
INDUSTRY